Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clark Cutrer
Observed name:
C Cutrer
Institution:
University of Tennessee Medical Center
Observed institutions:
University of Tennessee Medical Center,
University of Tennessee at Knoxville
OpenAlex ID:
A5115009225
MM-353: Trial in Progress: Phase 2 SubQSA Study of Subcutaneous (SC) Isatuximab (Isa) Administered by an On-Body Delivery System (OBDS) in Combination With Weekly Carfilzomib and Dexamethasone (Kd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2025
·
Tondre Buck
, Clark Cutrer
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Trial in Progress: Phase 2 Study of Subcutaneous Isatuximab, Administered By an on-Body Delivery System, in Combination with Weekly Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (SubQSA)
2024
·
Tondre T. Buck
, Clark Cutrer
, et al.
·
Blood
·
1
PDF
“Rev”-ing up the lungs: a case of lenalidomide-induced pneumonitits and pleural effusions”
2024
·
C Cutrer
·
The American Journal of the Medical Sciences
·
1
PDF
Iopofosine I-131 after BTK inhibitors in Waldenström macroglobulinemia: CLOVER-WaM subgroup efficacy and safety.
2026
·
Jarrod Longcor
, Sikander Ailawadhi
, et al.
·
Journal of Clinical Oncology
Impact of geographic distance and residential setting on overall survival in patients with Acute Myeloid Leukemia
2025
·
Warner Thomas
, Sunpil Hwang
, et al.
·
Blood
PDF
Itching for a diagnosis: Early T-cell Precursor Acute Lymphoblastic Leukemia presenting as a rash with pancytopenia
2025
·
Clark Cutrer
, Ronald Hamrick
, et al.
·
International Journal of Cancer Care and Delivery
When cancer is the answer, tissue is the issue: Diagnosing Advanced Mantle Cell Lymphoma in a patient presenting with pancytopenia
2025
·
Soham Nadkarni
, Sidharth Mahajan
, et al.
·
International Journal of Cancer Care and Delivery
POSTER: MM-353 Trial in Progress: Phase 2 SubQSA Study of Subcutaneous (SC) Isatuximab (Isa) Administered by an On-Body Delivery System (OBDS) in Combination With Weekly Carfilzomib and Dexamethasone (Kd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2025
·
Tondre Buck
, Clark Cutrer
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
338 A rare manifestation of HIV-related lymphoma: plasmablastic lymphoma
2025
·
S Weston
, C Cutrer
, et al.
·
The American Journal of the Medical Sciences
Evans syndrome: an elusive etiology of an uncommon phenomenon
2024
·
L Shaver
, C Cutrer
·
The American Journal of the Medical Sciences
PDF
Show more works
View as search
Works count:
10
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
